← Browse by Condition
Medical Condition
brain tumor
Total Trials
13
Recruiting Now
13
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2
NCT02800486 Phase 2
Recruiting
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Enrollment
37 pts
Location
United States
Sponsor
Northwell Health
NCT04699773
Recruiting
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Enrollment
32 pts
Location
United States
Sponsor
University of Maryland, Baltim...
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Enrollment
48 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
NCT06229483 Phase 3
Recruiting
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
Enrollment
102 pts
Location
Canada
Sponsor
Stephen Lownie
NCT05342454
Recruiting
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Enrollment
1,720 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03684109
Recruiting
Non-invasive Glioma Characterization Through Molecular Imaging
Enrollment
30 pts
Location
United States
Sponsor
University of Miami
NCT04692337
Recruiting
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT06930846
Recruiting
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce...
NCT06496971 Phase 3
Recruiting
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Enrollment
32 pts
Location
Taiwan
Sponsor
NaviFUS Corporation
NCT06381531
Recruiting
Tracing Brain Tumors Through Deep Time
Enrollment
10,000 pts
Location
India
Sponsor
Tata Memorial Centre
NCT05629702 Phase 2
Recruiting
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Enrollment
120 pts
Location
United Kingdom
Sponsor
University of Birmingham
NCT06810544 Phase 1, Phase 2
Recruiting
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Enrollment
191 pts
Location
United States
Sponsor
Tango Therapeutics, Inc.
NCT07105358
Recruiting
Visual Plasticity Following Brain Lesions
Enrollment
30 pts
Location
United States
Sponsor
Georgetown University